Trial site
Heidelberg
- 5running trials
- 15closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- High blood pressure3 trials
- Pulmonary arterial hypertension3 trials
- Acute myeloid leukaemia2 trials
- Heart failure2 trials
- Lung cancer2 trials
- Multiple sclerosis2 trials
- Myelodysplastic syndromes2 trials
- Chronic myeloid leukaemia1 trial
- Familial hypercholesterolaemia1 trial
- Glioblastoma1 trial
- Hidradenitis suppurativa1 trial
- Liver and biliary tract cancer1 trial
- and 5 more
- Phase
- Phase 38 trials
- Phase 26 trials
- Phase 13 trials
- Phase 1/21 trial
- Status
- Completed10 trials
- Terminated5 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals20 trials
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- Multiple sclerosis1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Characterizing Guideline Adoption and Treatment Quality in Clinical Routine of German HFrEF Care
Terminated
Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
Terminated
Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension
Completed
Completed
Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis
Completed
Terminated
Terminated
Completed
Completed
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
Completed
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026